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SUMMARY
This study investigated the signiﬁcance of serum complement on transmission-reducing activity (TRA) of ﬁeld sera
from 24 infected Plasmodium falciparum gametocyte carriers (from Cameroon) against cultured NF54 P. falciparum.
Laboratory-rearedAnopheles stephensiwere given infectious bloodmeals prepared either with sera from naı¨ve Dutch donor
(AB type) or pair-matched ﬁeld serum samples, both with and without active complement. TRA of serum factors and host
complement on mosquito infection rate and oocyst intensity were divided into the various components involved in the
early stages of sporogony. The majority (>80%) of sera tested showed positive antibody titres to Pfs230, the relevant
complement-dependent target of transmission-reducing mechanisms. Regardless of the presence of active complement,
bloodmeals with ﬁeld sera exhibited signiﬁcantly lower infection rates and oocyst intensity than the control group.
Serological reactivity in Capture-ELISA against Pfs230 was signiﬁcantly correlated with the reduction of parasite infec-
tivity. Contrary to our expectation, the presence of active complement in the mosquito bloodmeal did not increase parasite
losses and therefore the magnitude of transmission reduction by individual immune sera. Our ﬁndings on P. falciparum are
consistent with previous studies on animal hosts of Plasmodium, indicating that early P. falciparum sporogonic stages
may be insensitive to the antibody-dependent pathways of complement in human serum.
Key words: Plasmodium falciparum, gametocyte carriers, complement, Anopheles stephensi, sporogony, transmission-
reducing immunity.
INTRODUCTION
Human malaria is caused by species of Plasmodium,
protozoan parasites transmitted by Anopheles
mosquitoes. The infection induces immunity to both
asexual and sexual stages of the parasite (Good and
Miller, 1989; Targett et al. 1990; Hommel, 1991)
and it is established that human antibodies against
sexual parasite stages can reduce the infectivity of
the parasite to mosquitoes, alleviating transmission
pressure and hence the disease burden at the popu-
lation level (Carter and Mendis, 1992; Shahabuddin
and Costero, 2001). When a mosquito takes a
bloodmeal on an infectious host, parasite sexual
stages undergo a complex developmental cycle,
initially conﬁned to the midgut (Sinden, 1983), and
free-living parasite stages are therefore exposed to
immune attack by antibody and cell-dependent
eﬀectors either ingested along with the mosquito
bloodmeal (Carter et al. 1988; Lensen et al. 1998) or
released in response to invasion (Richman et al.
1997; Sinden, 2002; Tahar et al. 2002). Detailed
analysis of the contribution of vertebrate host-
related or vector-borne factors acting upon the de-
velopment of malaria parasites within mosquitoes
and characterization of the sexual stage(s) sensitive
to each determinant is relevant to any strategy
aiming at immune-mediated inhibition of trans-
mission.
Immune-dependent inhibition of parasite infec-
tivity by host blood factors involves a variety of
sexual-stage antigens of the parasite as targets
(Vermeulen et al. 1985; Carter et al. 1988; Naotunne
et al. 1993; Kaslow et al. 1994 ), most of which are
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still only poorly characterized (Kaslow et al. 1994).
Nonetheless, 2 major surface antigens on P. falci-
parum gametocytes, namely Pfs48/45 and Pfs230,
are synthesized early during gametocytogenesis and
expressed as a complex on gametes within the
mosquito midgut (Kumar, 1987; Kumar and Carter,
1984; Rener et al. 1983). Antibodies to these surface
proteins have been observed in humans exposed to
endemic malaria (Graves et al. 1988; Premawansa
et al. 1994; Roeﬀen et al. 1995a, b) and can
be induced experimentally by immunization with
speciﬁc gamete antigens (Carter and Gwadz, 1980;
Kaslow et al. 1991; Carter et al. 2000). Monoclonal
antibodies (MoAb) against Pfs230 and Pfs48/45 have
been shown to reduce or completely block infectivity
of Plasmodium to mosquitoes (Rener et al. 1980;
Roeﬀen et al. 1995b). These surface proteins provide
a basis for the development of transmission-blocking
vaccine (Carter et al. 2000). Themechanismwhereby
Plasmodium stages that are conﬁned to the lumen of
the midgut succumb to the immunity elicited by
Pfs230 and Pfs48/45 has been under intense scrutiny.
It is established that antibodies to sexual stage anti-
gens are key mediators of Plasmodium killing within
mosquitoes (Carter and Mendis, 1992) and whilst
there is evidence as to where and when during the
sporogonic development this suppression may occur
(Shahabuddin and Costero, 2001; Sinden et al. 1996;
Gouagna et al. 2004) it is unclear as to which immune
eﬀectors are the most crucial. Contrary to the eﬀects
of anti-Pfs48/45 antibodies that appear to be based
on complement-independent mechanisms, naturally
acquired antibodies to Pfs230 are fundamentally
of complement-ﬁxing IgG subclasses (IgG1 and/or
IgG2 antibodies) (Read et al. 1994; Roeﬀen et al.
1995b). Proof that one of the other complement
pathways may eﬀectively mediate suppression of
Plasmodiumwithin themosquito has been achieved in
experimental laboratory models, namely P. gallina-
ceum (Grotendorst et al. 1986; Grotendorst and
Carter, 1987), P. yoelii (Tsuboi et al. 1995) and
P. berghei (Margos et al. 2001). Also, the eﬀects of
the host’s complement system on extracellular
parasite stages have been demonstrated in several
insect-transmitted haemoﬂagellates species namely
Trypanosoma (Nogueira et al. 1975), Leishmania
(Pearson and Steigbigel, 1980). Similar experiments
on the eﬀect of host complement on human
Plasmodium (e.g. P. falciparum) transmission have
rarely been reported previously (Healer et al. 1999).
In laboratory experiments, however, more eﬀective
complement-dependent suppression of infectivity of
malaria parasites to mosquitoes has been found in
several examples involving monoclonal antibodies
against gametes (Kaushal et al. 1983; Rener et al.
1983; Roeﬀen et al. 1995b ; Healer et al. 1997). Thus,
the level of parasite response to serum complement
may be one of the key determinants for sporogonic
development.
Quantiﬁcation of the eﬀect of host complement
and/or its interaction with other factors involved
in the passage of malaria parasites from man to
mosquitoes is not only relevant to the understanding
of natural factors aﬀecting malaria transmission but
also important for the development of eﬀective
malariatransmission-blockingvaccines.Hereweused
ﬁeld sera from naturally infected gametocyte carriers
to investigate the role of complement, alone or in
association with naturally acquired transmission-
reducing immunity, on parasite transmission.
The contribution of speciﬁc antibodies against
Pfs230, the relevant target of complement-mediated
transmission-reducing mechanisms (Roeﬀen et al.
1993; Healer et al. 1999), was also assessed. Since a
negative eﬀect of endemic sera on P. falciparum
malaria transmission to the vector has been reported
in previous studies (Mulder et al. 1994; Roeﬀen et al.
1995a, b ; Lensen et al. 1996; Drakeley et al. 1998;
Mulder et al. 1999), we speciﬁcally looked at the
association between repeated stage-speciﬁc parasite
killing during early P. falciparum development and
the overall reductions of oocyst prevalence and
infection intensity within An. stephensi mosquitoes.
MATERIALS AND METHODS
Human sera
Field sera were collected duringmalaria transmission
studies reported previously (Gouagna et al. 2004).
Brieﬂy, Plasmodium falciparum gametocyte carriers
were recruited from cross-sectional parasitological
surveys among resident villagers of Mengang
(100 km from Yaounde´). Malaria is highly endemic
in this area with seasonal transmission (Meunier et al.
1999; Bonnet et al. 2002). Thick smears were stained
for 15 min with 10% Giemsa and examined with
a light microscope (100r oil immersion lens).
Volunteer gametocyte carriers (5–10 years old) and
their parents were informed about the purpose of the
study and asked to cooperate upon oral consent. The
Cameroonian scientiﬁc and ethical review com-
mittees approved all recruitment and experimental
procedures reported here. Each selected gametocyte-
positive patient provided 6 ml of venous blood that
was collected into a sterile glass tube without anti-
coagulant. These blood samples were allowed to clot
for 20 min at room temperature and centrifuged at
2000 g for 10 min in a centrifuge set at 37 xC.
Sera were collected and frozen at x20 xC for sub-
sequent bioassay experiments,which took place at the
Catholic University of Nijmegen, The Netherlands.
A single pool of non-immune sera obtained from
Dutch blood-bank donors (AB type) that were tested
negative in the standardmembrane feeding assay was
used throughout for all infection experiments, both
as the source of complement and for control assays
(Van der Kolk et al. 2006).
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Serological assays for speciﬁc antibodies
against Pfs230
In order to assess serological correlates of comp-
lement-dependent TRA, all ﬁeld sera were analysed
by capture ELISA for the presence of antibodies
against P. falciparum sexual-stage antigens, mainly
the Pfs230 which is the relevant target of comp-
lement-dependent transmission-reducing mechan-
isms. In brief, antibodies speciﬁc to Pfs230 were
assayed in ‘Capture ELISA ’ by coating 10 mg/ml of
anti-Pfs230 mouse mAb 63F2A2 in phosphate buf-
fered saline (PBS, pH 7.4) on Sterilin ELISA plates
(PS, ref 53011, International Medical Products
B.V., Zutphen, The Netherlands). Plates were
blocked with 5% low-fat dry milk (Marvel, Premier
International Foods Ltd, Spalding, Lines, UK)
in PBS. For Pfs230 antigen capture, plates were
incubated with gametocyte extract (250 000 parasite
equivalents/well). Sera (1 : 100 dilution) were added
to the wells and incubated for 2 h. Bound IgG anti-
bodies were detected by horse-radish-peroxidase
(HRPO)-labelled goat anti-human IgG (Pierce
31 412). Wells were washed 3 times with PBS and
subsequently incubated with tetramethyl benzidine
(TMB) substrate solution for 20 min. The colour
reaction was stopped with 4 M H2SO4, and optical
density (OD) read at 450 nm (Anthos 2001 micro-
plate reader: Labtec BV). All incubations were
carried out at room temperature. All serum samples
were tested in duplicate with a concurrent positive
control and a minimum of 3 negative (Dutch blood-
bank donor) controls per plate. Sera were considered
positive if the OD exceeded 3 standard deviations
above the mean of negative controls.
Blood preparation for membrane feeds
We used the human malaria, P. falciparum, NF54
laboratory isolate because of its highly infectious
characteristics (Ponnudurai et al. 1982). All parasite
batches had undergone fewer than 10 serial passages
in the automated ‘tipper’ system prior to use in
experiments described below. After 14 days in
culture, gametocytaemia (proportion of red blood
cells infected with sexual forms of parasites), and the
red blood cell (RBC) density were measured prior
to bloodmeal preparation. The exact number of
gametocytes was estimated for the time immediately
preceding the membrane feed. Consequently,
gametocytes were counted per 1.25r103RBCs using
a coulter counter (Luton, UK). Gametocytaemia was
estimated from the product of RBC densities and
parasites per RBC. The male/female gametocyte
ratio in infectious blood of the diﬀerent experimental
trials was approximately 1/3 (i.e. the number of fe-
male gametocytes higher than the number of males).
The culture material containing about 0.3 ml of
gametocyte-positive packed cells (1%) was spun at
500 g for 2 min. The supernatant was carefully
removed and the pellet containing parasitized red
blood cells (RBC) was mixed with 0.75 ml of freshly
washed and pre-warmed uninfected RBC from an
‘AB’ group Dutch donor (Lensen et al. 1996).
A volume of 150 ml of the parasitized RBC suspen-
sion was quickly added to each ﬁeld-collected serum
(OWN) in the presence and absence of active human
complement. All gametocyte carriers’ OWN and
control (AB) sera were initially heat inactivated at
56 xC for 30 min, in order to disable the complement
activity. A volume of 90 ml of each inactivated ﬁeld
and inactivated control serum sample was added to
30 ml of freshly prepared AB donor serum that was
not heat treated, in order to restore complement
activity. In parallel, samples of 120 ml complement-
depleted samples of OWN serum andAB serumwere
conditioned at 37 xC. In the second step, each serum
preparation (with and without complement) was
added to150 ml of freshlywashedhuman erythrocytes
(50% ﬁnal haematocrit) in vials prior to the feed.
The physiological activity of complement in these
AB pool sera was tested in a series of preliminary
experiments, which showed that bloodmeals mixed
with mouse 63F2A2.2a MoAb (an IgG2a switch
variant of the IgG1 isotype against Pfs230) (Roeﬀen
et al. 1995b) and active complement achieved TRA
over 90% in An. stephensi. These preliminary ex-
periments (unpublished data) were important, be-
cause technical bias due to inadequate blood
preparation could theoretically alter the infection
outcome. Like in previous experiments reported by
Roeﬀen et al. (1995b) this pre-test provided evidence
that the use of 30 ml of untreated normal AB donor
serum is adequate to ensure a physiological-suﬃcient
level of complement in the bloodmeal.
Mosquitoes and experimental infections
The membrane feeding assay used in this study
has the advantage for experimental investigation of
clear-cut TRA in which parasite responses can be
monitored in standardized and controlled conditions
using the highly infectious NF54 gametocyte strain.
Female An. stephensi, 2 to 3 days old, were drawn
from the same colony cohort and used in these ex-
periments. Although An. stephensi is not the natural
vector for P. falciparum, routine experiments with
cultured NF54 isolates showed this species to
become infected reliably using the membrane feed-
ing assays (Ponnudurai et al. 1982; Roeﬀen et al.
1995a, b ; Lensen et al. 1996;Mulder et al. 1999; Van
der Kolk et al. 2005). During each trial, 4 batches of
100 mosquitoes each were randomly constituted and
starved 5–6 h prior to the feed. Using previously
described feeding procedures (Ponnudurai et al.
1989), they were infected via mini-feeders containing
mature gametocytes from cultured parasite lines
re-suspended in either individual ﬁeld sera under test
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(OWN) or control sera (AB). These pair-matched
feeds were performed simultaneously, each with
blood mixtures containing either a complement-rich
serum or complement-deﬁcient (heat-inactivated)
serum. Mosquitoes were allowed to engorge each
blood preparation for 15 min through a Paraﬁlm1
membrane, warmed to 37 xC with a miniglass water
jacket. After feeding, all unfed mosquitoes were re-
moved and the remaining were kept under laboratory
conditions (25–28 xC, 80% RH) with daily access to
10% sucrose solution.
Mosquito dissection and detection of early parasite
stages and oocysts
Contrary to previously reported transmission studies
that assessed only the overall level of reducing
activities at the oocyst stage (Roeﬀen et al. 1995a, b ;
Lensen et al. 1996; Mulder et al. 1999; Van der Kolk
et al. 2005, 2006), here, we quantiﬁed the inhibiting
eﬀect of serum and complement component on the
various sporogonic stages: gametes, zygotes, ooki-
netes and oocysts. Therefore, stage-speciﬁc parasite
loads within individual mosquitoes that had been fed
bloodmeals with control sera and ﬁeld serum, with
and without a functional host complement were
assessed at 30 min, 3 and 24 h, post-infection by
immuno-ﬂuorescence staining of individual midgut
homogenates (Gouagna et al. 1998, 2004). Sche-
matically, pools of 5 mosquitoes each were dissected
in phosphate-buﬀered saline (PBS, pH7.2) at 30 min
post-feeding and their midguts were crushed and
homogenized. The homogenates were incubated
with ﬂuorescein-isothiocyanate (FITC)-conjugated
anti-Pfs48/45 monoclonal antibody (MoAb), in
0.05% Evans blue for 30 min at room temperature.
Following incubation, preparations were washed
with PBS (pH 7.2) and mounted under calibrated
Bu¨rker-Tu¨rk counting chambers covered with
24r24 mm no. 1 cover-slips and examined with
an incident ﬂuorescence light microscope (50r,
immersion lens) to detect gametes.
For other pre-oocyst stages, samples of 5 mos-
quitoes per group were dissected at 3 h post-feeding
(for zygotes and macrogametes both known as round
forms) and 20–24 h post-feeding (for ookinetes).
Instead of using MoAb against Pfs48/45 which is
already shed on zygotes and ookinetes, midguts were
homogenized and stainedwith FITC-labelledMoAb
against Pfs25, the major antigen present on pre-
oocyst stages of the malaria parasite. Midgut prep-
arations were processed as described above. In
order to assess overall TRA, the remainder of the
mosquitoes (>30 mosquitoes per batch) that took
‘OWN’ or control bloodmeal were kept in an in-
sectary (approximately 26 xC and >80% relative
humidity) for 7 days and subsequently dissected to
determine the presence of oocysts (stained with
mercurochrome 2%) on midgut. Both the presence
and absence of oocysts were recorded on each
occasion.
Estimation of transmission-reducing activity (TRA)
The overall transmission level was expressed as the
proportion of infected mosquitoes (prevalence) and
the mean oocyst number per mosquito (intensity).
TRA of each ﬁeld serum was obtained by expressing
the level of oocyst infection in the OWN group as the
percentage of that in the AB group from each paired
experimental feed. Various indicators have been
proposed previously to measure the magnitude of
immune-dependent regulation of malaria trans-
mission: (i) the standardized diﬀerence between the
mean oocysts in control and experimental feeds (Van
der Kolk et al. 2005) and (ii) the ratio of the oocyst
densities in the test group relative to its pair-matched
control (Lensen et al. 1996), or (iii) the comparison of
prevalences of infected mosquitoes (Mulder et al.
1994) between test serum and non-immune serum.
However, it is not known which of the indicators
proposed is most suited to describe the full picture
of transmission-reducing patterns under ﬁeld con-
ditions. Based on previous reports (Roeﬀen et al.
1995a, b ; Mulder et al. 1999), the commonly used
‘R-value’ was chosen as the privileged indicator of
serum-dependent regulation of transmission. The
following formula was used: R/100=((TcxTi)/Tc),
where Tc is the geometric mean of oocysts number
observed in the control group with non-immune sera
and Ti is the geometric mean oocyst number ob-
served in mosquitoes that fed on each test serum ‘i’.
TRA of test sera was divided into 3 categories ac-
cording to R-values: Blocking (Ro90%), Reducing
(30%oR<90%), and Non-blocking (R<30%)
(Lensen et al. 1996).
The total variation in the level of infectivity of each
parasite lot can be divided intomortality components
involving all the major steps in sporogonic de-
velopment. Therefore, data for macrogametocytes,
macrogametes, round forms (Robert et al. 1995),
ookinetes and oocysts were computed in the form of
a life table, thus permitting deﬁnition of where
the blockade or the reduction occurred. Interstage
parasite losses were estimated at each transition by
the coeﬃcient of mortality (k-values) as described
previously (Vaughan et al. 1992; Gouagna et al.
1998). In brief, the conversion rate of gametocytes
into gametes was the percentage of gametocytes
present in the bloodmeal that escaped from the host
cell and subsequently expressed the Pfs48/45 protein
on their surface (see the detection method). The
conversion rate of gametes into round forms (Robert
et al. 1995) was the percentage of gametes that
underwent exﬂagellation and fertilization, detected
with anti-Pfs25 monoclonal antibody at 3 h post-
feeding. The conversion rate of gametes/zygotes into
ookinetes was the percentage of female gametes that
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developed within 20–24 h into ookinetes of the total
of parasites (gamete and zygote) counts recorded at
3 h post-feeding.
Statistical analyses
All statistical procedures were performed using
SPSS 11.0 for Windows (SPSS, Inc., Chicago, IL).
Separate analyses were done both at group level
(centring the interest on the group eﬀect represented
in the data) by combining data from feeding series in
order to detect the source of variability in infection
outcomes and on individual infection experiments to
account for diﬀerences in TRA between gametocyte
carriers’ sera.
At group level, infection outcomes (infection rate,
oocyst intensity and mean proportional parasite
losses) obtained in both OWN and AB were com-
pared with respect to complement. Therefore, the
Pearson’s chi square test was applied to test the
association between the percentages of infection
generating feeding experiments within each group.
Our data consisted of 4 response variables: infection
rate, parasite intensity, interstage parasite losses and
categories of TRA. Each one was analysed separately
using General Linear Models (GLM), which
examine the contribution of each eﬀect. Individual
infection assay (coded as 1–24), infection group
(OWN and AB), complement treatment (active or
heat-depleted) were added as explanatory variables.
Interactions between all explanatory variables were
also ﬁtted, where signiﬁcant (P<0.05). Prior to
analyses, mosquito infection rates were square-root
arcsine-transformed while stage-speciﬁc parasite
counts per infected mosquito were log10 transformed
(number of parasites+1) to bring their distributions
close to normal.
At individual level, the TRA of each serum was
expressed as a percentage of that in the AB group
from each paired experimental feed (see above,
Lensen et al. 1996), and the GLM was used to test
the eﬀect of complement activity and Pf230 antibody
level (with OD values for speciﬁc antibodies as con-
tinuous variable) on TRA. In addition to the main
eﬀect, interaction eﬀects between all explanatory
variables were also ﬁtted. Pearson correlations were
used (1) to determine whether parasite mortality
rates obtained from the ‘within-group analyses’ were
consistent across all infection experiments and (2) to
correlate the presence of speciﬁc antibodies to the
TRA of the sera that were tested.
RESULTS
Complement-dependent TRA of 24 serum samples
from naturally infected gametocyte carriers (OWN)
were evaluated using cultured NF54 P. falciparum
gametocytes and laboratory-reared Anopheles
stephensi. Infection trials were performed 2 or more
days apart and on the day of each experiment, 2
separate serum samples were tested simultaneously,
with and without complement and a single control
(non-immune serum, AB group) was therefore con-
sidered for both serum samples. Thus, a total of 48
(24 ﬁeld serar2 complement treatments) and 24 (12
control serum samplesr2 complement treatments)
experimental feeds were eﬀected. In addition to
assessing the eﬀect of complement on (1) the pro-
portion of infected mosquitoes, (2) oocyst intensity
and (3) stage-speciﬁc parasite losses, we also assessed
the contribution of speciﬁc antibody level in each
serum on the relative TRA.
Comparison of the complement eﬀect in OWN
and AB infections experiments
Figure 1 depicts the inﬂuence of serum-complement
treatment combinations on the proportion of
mosquitoes becoming infected within the infection-
generating experiments. The means and medians of
infection rate and oocyst intensity were not equal,
suggesting a non-symmetrical distribution of these
outcome variables. Therefore, only medians of
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Fig. 1. Eﬀect of host serum factors on NF54 Plasmodium
falciparum infection rate in Anopheles stephensi. Data are
presented separately for pairs of infection experiments in
which mosquitoes were allowed to feed on a gametocyte-
infected bloodmeal mixed either with individual serum
samples from ‘immune’ gametocyte carriers (OWN) or
control sera from naı¨ve blood donors (AB type), assayed
both in the presence of active complement and after
complement activity has been heat-depleted. Boxplot
displays for each of the groups the median (horizontal
bar), the interquartile range (box) and 5th to 95th
percentile range (error bar).
Serum complement and transmission-reducing activity 1319
infection outcomes (and interquartile ranges, IQR)
are reported throughout. The median of infection
rate from OWN bloodmeal was signiﬁcantly lower
than from AB blood, both in active complement
[73 (73.5) % versus 82 (20) %)] (F1,35=4.44,P=0.04)
and complement-deﬁcient group [77 (68) % versus
85 (20) %] (P=0.04). Although the proportion of
infected mosquitoes recorded in the OWN group
with active complement tended to be lower than that
in the complement-deﬁcient group, the diﬀerence
was not statistically signiﬁcant at the 0.05 level.
(F1,46=1.68, P=0.56). Similarly, no signiﬁcant ef-
fect of complement on the proportion of mosquitoes
becoming infected after ingestion of infectious
bloodmeal with control sera was found (F1, 22=0.02,
P=0.84), suggesting that transmission of P. falci-
parum to mosquitoes was not sensitive to comple-
ment alone.
The number of oocysts per mosquito was 4 times
lower in OWN [Median (IQR)=4.1 (21.2) oocysts
per mosquito] than in AB group [17.6 (23.9) oocysts
per mosquito] (F1,35=4.7, P=0.03) when mos-
quitoes were provided with a bloodmeal with active
complement. The same trend in oocyst intensities
was observed between OWN and AB when sera were
heated [4.6 (16.8) oocysts per mosquito in OWN
versus 22.2 (32.7) oocysts per mosquito in AB group]
(F1,33=6.6, P=0.01). These results also indicate
that the average numbers of oocysts per infected
mosquito was not aﬀected when complement
activity was restored, both in OWN (F1,46=0.10,
P=0.74) and AB group (F1, 23=0.02, P=0.87).
Transmission-reducing activity (TRA) of immune
sera against P. falciparum in mosquitoes
Table 1 shows the percentages of anti-Pfs230
positive ELISA titres and the distribution of the
number of reducers and non-reducers with respect
to complement. The relative TRA of each serum
sample was expressed as a percentage reduction of
oocyst numbers in the OWN group relative to that of
the control with which it was performed. Regardless
of the anti-Pfs230 reactivity (see last column in
Table 1), the numbers of sera that signiﬁcantly
suppressed oocysts formation (with Ro90%) and
those that exhibited no signiﬁcant suppression of
transmission (0<Rf30) were relatively greater
in the presence of active complement than in the
heat-treated group. TRA was highly variable among
the various sera tested (F22, 24=13.18, P<0.001).
Overall, the percentage of sera that signiﬁcantly
suppressed infectivity in the presence of active
complement was not signiﬁcantly higher than that
in the heat-treated group (Pearson Chi-Square:
P=0.35). Two serum samples that reduced parasite
infectivity in the absence of active complement
completely prevented oocyst formation in mos-
quitoes when complement activity was restored.
In contrast, 4 other sera that signiﬁcantly reduced
transmission in the absence of complement became
paradoxically less potent in generating the same level
of activity in the presence of active complement.
Relationships between Pfs230 speciﬁc antibodies
and complement-dependent TRA of individual
serum samples
Serological data were analysed with reference to the
predictive ability to induce TRA in the membrane-
feeding assay. For instance, we tested whether the
observed sero-reactivity to Pfs230 correlated with a
reduction in transmission capacity, as deﬁned by the
R-value (Table 1). Of the sera that were positive
for Pfs230 antibody in ‘Capture ELISA ’ (83.3%),
2 (10%) elicited transmission reduction and 15 (75%)
Table 1. Eﬀects of host complement and Pfs230 antibody response on TRA against Plasmodium
falciparum in Anopheles stephensi
(An infectious bloodmeal with culturedP. falciparum gametocytes (NF54 isolate) was provided toAn. stephensi either in the
presence of gametocyte carriers serum sample (OWN) or control sera from malaria naı¨ve Dutch blood donors (AB group),
both in the presence of active complement or heat-depleted (56 xC) of complement activity. Antibodies speciﬁc to Pfs230
were assayed in ‘capture ELISA’. TRA was estimated as a ratio of the oocyst densities in the test group relative to its
pair-matched control (Lensen et al. 1996).)
Sera with TR-activity (%)
Pfs230 antibody response
TR-level
Serum
complement Negative Positive Total
Blocker: Ro90% Active 1 (6.3) 15 (93.8) 16
Heat-depleted 1 (7.1) 13 (92.9) 14
Reducer: 30%oR<90% Active 1 (33.3) 2 (66.7) 3
Heat-depleted 1 (14.3) 6 (85.7) 7
Non-reducer: R<30% Active 2 (40.0) 3 (60.0) 5
Heat-depleted 2 (66.7) 1 (33.3) 3
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completely suppressed transmission in the presence
of complement. Two sera which were negative for
Pfs230 did, however, mediate signiﬁcant TRA in the
presence of complement. Overall, the magnitude of
complement-dependent TRA was not signiﬁcantly
greater in sera that showed sero-reactivity to Pfs230
than those that did not (x2=3.8, D.F.=2, P=0.32).
Nevertheless, there was a signiﬁcant linear relation-
ship between Pfs230 antibody titres [Median OD
(IQR)=0.23 (0.21)] and TRA, both in the presence
(Pearson’s correlation coeﬃcient=0.41, P=0.02)
and absence of active complement (Pearson’s corre-
lation coeﬃcient=0.45, P=0.01) (Fig. 2). Restrict-
ing the analysis to the sera exhibiting signiﬁcant
TRA (Ro90% and 30%oR<90%, n=19), the odd
ratio for the relationship between anti-Pfs230 anti-
body titres and the percentages of infection reduction
in mosquitoes that fed heat-treated bloodmeal
[OR=1.29, 95%CI (0.95 – 2,42),P=0.05] increased
substantially after the activity of serum complement
was restored ([OR=1.4, 95% CI (1.02 – 2,44), P=
0.006]). This result suggests that there could be some
synergistic eﬀect of serum complement on the ability
of anti-Pfs230 antibodies to reduce transmission.
Despite the observed relationships, the F statistic
further indicated that the inﬂuence of complement
activity alone (F1,36=1.32, P=0.73) or combined
with anti-Pfs230 antibody response (P=0.38) did
not account for the variability in the TRA.
Mechanisms responsible for the diﬀerential reduction
in P. falciparum transmission by individual
serum samples
The mechanistic basis of serum-mediated or
complement-dependent transmission reduction was
investigated by the estimate of the percentage
reduction of macrogametes, gametes/zygotes and
ookinetes within mosquitoes at 30 min, 3 h and 24 h
post-feeding, respectively. As shown in Fig. 3,
parasite numbers declined from one stage to the
next in all serum and complement treatment groups.
There was no signiﬁcant diﬀerence in mean numbers
of macrogametes gamete/zygotes and ookinetes in
mosquitoes that fed on bloodmeal with AB control
sera and active complement and those from the
matched-group with depleted complement activity
(Fig. 3). Mosquitoes that were fed bloodmeals with
OWN sera and active complement tended to exhibit
lower mean numbers of macrogametes, round-forms
and ookinetes than those fed bloodmeals with heat-
depleted complement (Fig. 3). Throughout the early
sporogonic development, however, no meaningful
complement-dependent reduction of parasite num-
bers was evident.
From those declining parasite numbers, we
derived stage-speciﬁc mortality rates at successive
developmental transitions and subsequently related
the magnitude of parasite losses to complement
treatments (Table 2). In both the OWN and AB
group, substantial parasite losses were observed
across diﬀerent parasite developmental stages within
mosquitoes. Consistently in all infection trials, the
interstage parasite mortality rates were signiﬁcantly
higher in OWN than in AB, both when mosquitoes
had fed on a bloodmeal with active and inactivated
complement. In most cases except for 5 immune
serum samples (data not shown), heat-treated ﬁeld
serum samples suppressed as eﬀectively as the
matched samples with active complement (Table 2).
The bulk of serum-related TRA occurredmainly at 3
developmental transitions: from macrogametocytes
to macrogametes (F1,46=3.8, P=0.05), from gamete/
zygotes to ookinetes (F1,46=36.5, P<0.01) and from
ookinetes to oocysts (F1,46=12.2, P=0.001). Despite
the lack of signiﬁcant diﬀerences in parasite losses
among infected mosquitoes that received a blood-
meal with active complement and inactivated
complement, there were signiﬁcant diﬀerences in
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Fig. 2. The inﬂuence of serum complement on the
relationships between Pfs230 antibody titres and TRA
against Plasmodium falciparum in Anopheles stephensi.
Data for 24 pairs of infection experiments in which
batches of An. stephensi mosquitoes were given a NF54
gametocyte-positive bloodmeal prepared either (1) with
serum samples from naturally infected P. falciparum
gametocyte carriers (OWN) or (2) with non-immune sera
from malaria naı¨ve blood donors (AB type), both in the
presence of active complement and after complement
activity has been heat-depleted. All sera were tested using
‘capture ELISA’ and positive antibody titres were
calculated as the serum dilution given an optical density
greater than 3 standard deviations above the mean of
negative controls. In the GLM that included both
complement treatment and antibody response to Pfs230
as explanatory variables, only the antibody titre to
Pfs230, but not complement treatment, was signiﬁcantly
related to TRA, here expressed as a percentage reduction
of oocyst numbers in the OWN group relative to that of
the control with which it was performed (Lensen et al.
1996).
Serum complement and transmission-reducing activity 1321
cumulative parasite mortality (K-t between macro-
gamete and oocyst stage) associated with serum
sources: 2.7 (569-fold decrease) in OWN with
complement compared to 2.3 (195-fold decrease) in
the AB plus active complement group (F1,46=4.8,
P=0.03). Restricting the statistical analyses to the
sera exhibiting signiﬁcant TRA (n=19), with total
(Ro90%) and partial reducers (30%oR<90%) as-
signed a value of 1, and 0 for those without signiﬁcant
TRA (R<30%), the blockade in response to ﬁeld sera
occurred mainly at the gamete and ookinete stages
(data not shown). In the OWN group, there was a
consistent correlation between accumulated parasite
mortality (K-t) both with infection rate (Pearson’s
correlation coeﬃcient=x0.85, P<0.01) and oocyst
intensity (P coeﬃcient=x0.98, P<0.01). In con-
cordance with the previous analyses, there was still
no signiﬁcant eﬀect of serum complement on the
patterns of these relationships.
DISCUSSION
The present study was undertaken to determine the
role of host complement in immune-mediated TRA
of NF54 Plasmodium falciparum in laboratory-
infected Anopheles stephensi. Although the NF54
parasite strain was used in infection experiments
(Ponnudurai et al. 1982, 1989), the sera tested came
from 24 naturally infected P. falciparum gametocyte
carriers, for whom natural immunity was expected to
be stimulated by the presence of gametocytes. In
view of this, it was expected that the majority of
serum samples would reveal signiﬁcant TRA, which
possibly would be enhanced by the presence of active
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Fig. 3. Eﬀect of serum complement on early Plasmodium falciparum sporogonic development within Anopheles stephensi
fed on bloodmeals supplemented with immune and non-immune sera. Laboratory-reared An. stephensi were given
infectious bloodmeals prepared either with sera from naı¨ve Dutch donor (AB type) or pair-matched ﬁeld serum samples
(OWN), both with and without active complement. The number of macrogametocytes in the feed was similar for both
groups. At diﬀerent times following the infectious bloodmeals, mean parasite densities were estimated at each early
developmental stage including macrogamete, macrogamete/zygote or round form (Rd-form), Ookinete and Oocyst.
Average parasite density and standard error of the mean (error bars) from 24 independent infection experiments are
shown. In both the OWN and AB groups, there was no statistically signiﬁcant diﬀerence between the distribution
patterns of early sporogonic parasite stages in mosquitoes fed with bloodmeals with or without active complement.
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complement in the mosquito bloodmeal. The
evidence gathered from infection experiments per-
formed separately indicated that providing mos-
quitoes with bloodmeals incorporating immune sera
resulted in a substantial decline of eﬀective parasite
numbers at each developmental stage in the mos-
quito midgut, resulting in low oocyst production.
Both the proportion of infected mosquitoes and the
oocyst intensity were reduced by factors present in
the majority of immune sera tested, of which the
Pfs230 antibody was suspected to play an important
role, but in a manner uninﬂuenced by the presence
of the heat-labile principle or serum complement.
Indeed, it is established that natural transmission-
reducing immunity rests mainly on the action of
speciﬁc antibodies against antigens of the pre-oocyst
stages (Targett et al. 1990; Carter and Mendis,
1992). Contrary to previous reports (Premawansa
et al. 1994; Mulder et al. 1999), a correlation was
found between antibody titres to Pfs230 target and
TRA. It was expected that the presence of active
complement in the bloodmeals would increase the
rate and magnitude of TRA imposed by individual
immune serum. This expectation was supported by
previous laboratory studies (Tsuboi et al. 1995;
Grotendorst et al. 1986; Margos et al. 2001), but
surprisingly our data indicated that the mechan-
ism(s) involved in the inhibition of the sporogony
is not the early complement-dependent lysis of
macrogametes as previously observed in in vitro lysis
experiments (Grotendorst and Carter, 1987; Healer
et al. 1997; Williamson, 2003). Since adequate prep-
aration of the bloodmeal fed to mosquitoes in this
study ensured that the level of complement reached
the level normally found in serum (Roeﬀen et al.
1995b), it is not known why host complement,
despite being present in the bloodmeal, only poorly
contributed to TRA of our serum sample against
cultured P. falciparum within An. stephensi.
Host serum has multiple components that
may interfere with parasite development within the
mosquito. These include white blood cells, anti-
sexual antibodies, cytokines and complement. The
complement system which forms one of the main
eﬀector mechanisms of antibody-mediated immun-
ity, involves the action of 23–30 plasmatic proteins
(Umotong et al. 1994; Walport, 2001). Serum
complement has often been suspected to be in-
volved in gamete lysis or phagocytosis in vitro and
in vivo (Grotendorst and Carter, 1987: Roeﬀen et al.
1995b ; Healer et al. 1997), thereby aﬀecting malaria
transmission from vertebrate hosts to mosquitoes
but the expression of proteins by malaria parasites
that inhibit complement may also be implicated
(Grotendorst et al. 1986). Another possibility is that
immune serum probably lacks components that can
eﬀectively initiate complement activation within the
vector.
It is assumed that functions of naturally acquired
anti-Pfs230 antibody may require the activation of
cofactors such as serum complement to lyse the early
gamete stage, decreasing the numbers of oocysts.
Indeed, Quakyi et al. (1987) and Read et al. (1994)
have shown that only the isotypes of Pfs230 that ﬁxed
complement can eﬃciently lyse gametes and block
transmission in vitro. Roeﬀen et al. (1995b) further
demonstrated that speciﬁc-Pfs230 MoAbs of isotype
IgG2b and IgG2a, but not IgG1 isotype, are eﬀective
in reducing P. falciparum transmission only in the
presence of complement. This means that the role of
Table 2. Eﬀect of complement and host serum factors on early Plasmodium falciparum development in
Anopheles stephensi infections by standardized membrane-feeding assay
(An infectious bloodmeal with culturedP. falciparum gametocytes (NF54 isolate) was provided toAn. stephensi either in the
presence of gametocyte carriers serum sample (OWN) or control sera from malaria naı¨ve Dutch blood donors (AB group),
both in the presence of active complement (+Cplt) or after heat (56 xC) inactivation of complement activity (xCplt).Mean
parasite density was estimated at each early developmental stage including macrogametocytes (MGCT), macrogamete
(MGAM), gamete/zytgote or round forms (RDFORM), Ookinete (OOK) and Oocysts (OOC). k-I, mortality coeﬃcient
indicating interstage parasite losses between two consecutive developmental stages. k-T, accumulated mortality coeﬃcient
describing the overall losses between macrogametocytes and oocysts.)
Life transition
Mean parasite mortality coeﬃcients (x-fold decrease)
Immune serum (OWN)
N=24r2
p-valuea
Control AB serum
N=12r2
p-valuea+Cplt xCplt +Cplt xCplt
k-1 (MGCT – MGAM) 0.17 (1.5) 0.12 (1.3) 0.36 0.07 (1.2) 0.09 (1.2) 0.90
k-2 (MGAM – RDFORM) 0.38 (2.4) 0.36 (2.3) 0.20 0.26 (1.8) 0.29 (1.9) 0.53
k-3 (RDFORM – OOK) 1.21 (16.2) 1.24 (17.4) 0.85 0.63(4.3) 0.61 (4.0) 0.66
k-4 (OOK – OOC) 0.97 (9.3) 1.02 (10.5) 0.37 1.31 (20.7) 1.26 (18.4) 0.64
k-T (MGCT – OOC) 2.74 (561.2) 2.75 (572.1) 0.96 2.29 (196.5) 2.18 (153.0) 0.86
a The F test was used to compare mean mortality coeﬃcient at each transition between infection groups with and without
complement, the mean diﬀerence being signiﬁcant at the 0.05 level.
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complement in Pfs230-based transmission reduction
may be accomplished by an isotype-dependent
eﬀector mechanism (Healer et al. 1997). Our results
suggested a slight trend of decreasing parasite
infectivity due to serum complement which, how-
ever, was not statistically signiﬁcant. The low
complement-dependent inhibition of parasite infec-
tivity observed in this study cannot be explained in
the light of weak immune activity against Pfs230 in
the sera tested. In fact, gametocyte carriers from
whom our serum samples were collected live in an
area where malaria is highly endemic (Bonnet et al.
2002). Further, the frequency of anti-Pfs230 anti-
bodies is higher in gametocyte-positive individuals
than in their counterparts without gametocytes
(Roeﬀen et al. 1995b). In the present study the
prevalence of anti-Pfs230 antibodies in a single-
epitope capture ELISA was high indeed, and there
was signiﬁcant association between the antibody
level within serum samples that signiﬁcantly reduced
parasite transmission to mosquitoes, irrespective of
complement activity. Possibly, the absence of the
appropriate complement-ﬁxing anti-Pfs230 isotypes
(Quakyi et al. 1987; Read et al. 1994; Roeﬀen et al.
1995b), might account for the absence of an eﬀect of
complement in our serum samples. Previous studies
with Cameroonian sera (Mulder et al. 1999) and in
Sri Lanka residents (Premawansa et al. 1994) showed
nomeaningful association betweenTR-activities and
speciﬁc antibody response to Pfs230 antigens.
Nevertheless, surveys elsewhere revealed evidence of
serum positivity for anti-sexual stage antibody to
Pfs230 antigen that results in signiﬁcant levels of
inhibition of parasite infectivity to mosquitoes
(Graves et al. 1988; Healer et al. 1997; Williamson,
2003). Extending our interest to all possible factors
that could aﬀect parasite infectivity, the TRA rep-
resented in our data would have arisen due to several
physiological and immunological factors that our
study design did not allow us to look at. Of the host-
related immune factors, previous serological studies
in samples of Cameroonian gametocyte carriers have
indicated that the prevalence of an antibody-speciﬁc
response against Pfs48/45 was higher in gametocyte
carriers’ sera (60%) (Roeﬀen et al. 1995a). We
suspect the suppressive activity of speciﬁc antibodies
to Pfs48/45 on the early sporogonic development to
outweigh the lytic eﬀect of complement alone or
complement-dependent agglutination of gametes by
anti-Pfs230 IgG subclasses.
In all mosquitoes exposed to immune sera with
active complement, the numbers of viable macro-
gametes, gametes/zygotes, ookinetes and oocysts
were comparable to that in mosquitoes exposed to
complement-depleted bloodmeal. Our ﬁndings on
P. falciparum are consistent with previously reported
studies with P. berghei (Ranawaka et al. 1993;
Grotendorst and Carter, 1987). These authors have
shown that complement components are present and
active within mosquito midgut, at least within 2–3 h
following bloodmeal ingestion. However, emerging
P. berghei gametes and early zygotes may show re-
sistance against complement lytic activity during this
period, after which parasites became increasingly
sensitive to serum complement. Our analysis did not
allow us to verify whether the reduction of ookinetes
we observed in the group of mosquitoes fed active
complement reﬂected the sensitivity of this stage to
complement. During the development of ookinetes,
however, the major gamete surface proteins namely
Pfs230 and Pfs48/45 are shed and replaced by the
Pfs25 coat (Carter and Mendis, 1992). It has been
suggested that this antigen may play an important
role in both protecting and promoting ookinete
formation and its migration through the midgut
epithelium (Meis et al. 1989). In addition, ookinetes
are visible 6–12 h post-infection, coinciding with
the decline in complement activity as previously
shown by Margos et al. (2001). Thus any eﬀector
mechanism that requires host complement could not
possibly be involved in the reduction of ookinetes.
The observed inhibition of post-ookinete devel-
opment in this study may be the outcome of poten-
tially synergistic interactions between mosquito and
host-related factors. Indeed, the level of TRA is
intrinsically determined either by aspects of the host
immunity or parasite response to vector immunity
that also regulate its transmissibility (Richman et al.
1997; Dimopoulos et al. 1998; Blandin et al. 2004;
Osta et al. 2004). When comparing parasite mortality
rates from the experimental relative to the control
groups, we showed that host immunity only partly
explained parasite mortality, but elucidation of
the inﬂuence of other mosquito-borne factors, e.g.
defensive toxins, would be necessary in order to
understand the mechanistic basis of TRA exhibited
by each immune serum and complement inter-
actions. Across all experiments, there was a negative
association between overall variation in mortality
rate and infection intensity. This correlation, how-
ever, may have emerged only because of high mor-
tality enabled by immune factors across individual
sera, rather than because of the accrued impact of
serum-by-complement activity as parasites develop
within mosquitoes.
In conclusion, this study conﬁrmed that whereas
immune serum (and most likely serum with a posi-
tive antibody response against Pfs230 antigen) ap-
pears to cause signiﬁcant reductions of P. falciparum
infectivity within the An. stephensi midgut, host
complement did not play a major role in either
interstage parasite mortality rate or in the reduction
of infection rate and intensity. In terms of reducing
P. falciparum infections in mosquito, ‘ immune sera’
from naturally infected individuals do not necessarily
result in complete blockage, as in previous studies
(Drakeley et al. 1998; Mulder et al. 1999; Van der
Kolk et al. 2006). TRA against malaria parasites can
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be driven by a wide range of vector-borne factors
(reviewed by Shahabuddin and Costero, 2001), the
precise nature of which, under natural conditions,
remains elusive. An improved understanding of host-
parasite-vector interactions will allow assessment of
the epidemiological importance of each component
of the malaria life-cycle and perhaps provide crucial
insight that will facilitate the development and test-
ing of future control strategies such as transmission-
blocking vaccines (Carter et al. 2000) or genetic
engineering strategies (Riehle et al. 2003). Both
ﬁeld and laboratory-based studies routinely show
that P. falciparum successfully infects mosquitoes
despite undergoing a dramatic decrease in numbers.
Therefore, a complete blockade of the parasite de-
velopment process would be required to signiﬁcantly
reduce the impact of malaria in endemic areas.
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